Abstract
The immunogenicity of a virus vaccine against viral pneumoenteritis in young cattle was studied in laboratory animals. The results of the selection of optimal vaccine strains to study the effects of different inactivants on infectious rhinotracheitis virus, viral diarrhea, parainfluenza-3, respiratory syncytial virus, rotavirus and coronavirus are presented. The accumulation of avirulent vaccine virus strains was carried out using established virological methods on transplanted cell cultures of MDBC (calf kidney cells) and SPEV (fetal pig kidney cells). Theotropine and formalin were used as inactivating agents to develop inactivation regimes for vaccine strains - components of the experimental vaccine. The antigenic activity of attenuated strains of infectious rhinotracheitis virus, viral diarrhea, parainfluenza-3, respiratory syncytial virus, rotavirus and coronavirus on white mice and calves and the level of specific antibodies in the sera of guinea pigs immunized with vaccines using different adjuvants were studied. Avirulent strains of viruses were used in the design of a new virus vaccine against viral pneumoenteritis: infectious rhinotracheitis (IBR-VBF-VHAVM No. 404); diarrhea (VDVBF-VHAVM No. 406); parainfluenza-3 (PG-VBF-VHAVM No. 403); respiratory syncytial virus (RSV-VBF-VHAVM No. 405); rotavirus (RTV-VBF-VHAVM No. 401) and coronavirus (CV-VBFVHAVM No. 407). The selected vaccine strains are non-reactive and induce active production of antiviral antibodies in sufficiently high titres in both laboratory animals (white mice) and farm animals (cattle). The most effective inactivating agents are 0.1% theotropine and 0.2% formalin. Two types of oil-based adjuvants, ISA 15 and ISA 25, were used to select the optimal adjuvants for the design of the virus vaccine. Adjuvant ISA 15 was used at 15% of the antigen quantity, ISA 25 at 25%. The adjuvant IZA 15 at a concentration of 15% is the optimum adjuvant for the preparation of an experimental virus vaccine against viral pneumoenteritis in young cattle.
Published Version
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
